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Summary 
Cytokine-stimulated human osteosarcoma cells (MG-63) secrete several related chemotactic factors, 
including the neutrophil-activating protein interleukin 8 (IL-8) and the monocyte chemotactic 
protein (MCP)-I. We describe the isolation and characterization of two novel monocyte chemotactic 
factors from this tumor cell line. Although these proteins copurified with MCP-1 and Ib8 on 
heparin-Sepharose, they could be separated by cation-exchange fast protein liquid chromatography 
and reverse-phase high-performance liquid chromatography. The corresponding 7.5- and 11-kD 
proteins were NH2-terminally blocked but were identified by sequencing peptide fragments. 
They showed a primary structure mostly related to that of MCP-1 and were therefore designated 
MCpo2 and MCP-3, respectively. These molecules can be dassified in a subfamily of proinfhmmatory 
proteins  characterized  by the conservation of cysteine residues.  MCP-2  and MCP-3  are  also 
functionally related to MCP-1 because they specifically attract monocytes, but not neutrophils, 
in vitro. The chemotactic potency (specific activity) was comparable for all three MCPs. Intradermal 
injection of these proteins in rabbits resulted in selective monocyte recruitment in vivo. Since 
tumor cells are good producers of leukocyte chemotactic factors, it could be questioned whether 
these molecules can indirectly control tumor growth by attracting leukocytes or whether they 
rather promote invasion by the secretion of proteases from the attracted cells. 
C 
ell migration is an important phenomenon in inflam- 
mation and in the invasive behavior of tumors. In re- 
sponse to infection, phagocytes are attracted to the inflam- 
matory focus through the generation of chemotactic gradients. 
Recently, chemotactic factors belonging to a novel family of 
proinflammatory proteins have been identified (1-7). In con- 
trast to the classical chemoattractants (e.g., C5a, FMLP), these 
molecules specifically affect the migration of single types of 
leukocytes. Within this family of structurally related,  low 
relative molecular mass factors, II.-8 is a well-characterized 
neutrophil-activating protein (1-5). Ib-8 can be grouped into 
a class (designated CXC chemokines) based upon the posi- 
tion of the two NH2-terminal, conserved cysteines. Mono- 
cyte chemotactic protein  1 (MCP-1) 1 belongs  to a  second 
class (CC chemokines), in which these cysteines are adjacent 
(6, 7). MCP-1 is an attractant for monocytes but not for neu- 
trophils (6-8). Except for some platelet products, these inflam- 
matory proteins can be induced in various cell types (fibro- 
blasts, endothelial cells, monocytes, lymphocytes) in response 
1 Abbreviations used in  this paper: CPG, controlled pore  glass; GCP, 
granulocyte chemotactic protein; MCP, monocyte chemotactic protein. 
to a variety of stimuli, including cytokines (1-8). Several trans- 
formed ceil types have also been described to secrete these 
chemotactic factors. This implies that chemoattractants might 
play  a  role  in  tumor  biology  (9).  We  describe  here  the 
identification of two novel monocyte chemotactic factors iso- 
lated from stimulated osteosarcoma cells. Since the proteins 
were found to be biochemicaUy and biologically related to 
MCP-1,  they are designated MCP-2  and MCP-3. 
Materials  and Methods 
Production and  Purification of Monocyte Chemotactic Activity, 
Human MG-63 osteosarcoma cells (8, 10) were stimulated with 
pure human IblB or semi-purified cytokine derived from mitogen- 
stimulated mononuclear cells. After 5 h of induction, cell cultures 
were washed and incubated with serum-free or serum-containing 
(2% FCS) growth medium for 48 h at 37~  MCP (3 liters/batch) 
was concentrated and partially purified by adsorption to controlled 
pore glass (CPG-10-350; Serva, Heidelberg, Germany). The CPG 
eluate was further purified by antibody affinity chromatography 
using a polyclonal antibody to fibroblast-derived cytokine (11). Al- 
ternatively, MCP was purified by heparin-Sepharose (CL-6B; Phar- 
macia, Uppsala, Sweden) chromatography.  MCP was eluted in a 
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recovered by antibody or heparin-Sepharose chromatography was 
further purified by Mono S FPLC (Pharmacia) in 50 mM formate, 
pH 4.0. After an extensive wash with equilibration buffer, activity 
was eluted (1 ml/min) in a linear NaC1 gradient  (0-1 M) in 50 
mM formate, pH 4.0. 
Fractions were checked for purity by SDS/PAGE. Samples (3-20 
/~1) were loaded onto a linear gradient  (10-25%) polyacrylamide 
gel, and silver stained (8, 11). The relative molecular mass markers 
(Bio-Rad Laboratories, Richmond, CA) used were phosphorylase 
b (Mr 92,500), BSA (Mr 66,200), OVA (Mr 45,000), carbonic an- 
hydrase (Mr 31,000), soybean trypsin inhibitor  (Mr 21,500), lyso- 
zyme (Mr 14,400), and the low relative molecular mass marker 
(Pierce Chemical Co., Rockford,  IL) aprotinin  (M, 6,500). 
Identification of Monocyte Chemotactic Proteins by Sequence Anal- 
ysis.  MCPs were purified to homogeneity by reverse-phase HPLC 
(8). Active fractions from FPLC were analyzed on a 220  x  2.1- 
mm C-8 Aquapore P,.P-300  column (Applied Biosystems,  Inc., Foster 
City, CA) equilibrated with 0.1% TFA. Chemotactic activity was 
eluted with an acetonitrile gradient in 0.1% TFA at 0.4 ml/min. 
Tryptic fragments from 4/~g MCP were prepared by digestion 
with 0.2/~g bovine trypsin (sequencing grade; Boehringer Mann- 
helm, Mannheim,  Germany) for 18 h at 37~  (8). Alternatively, 
4/~g of MCP was digested by addition of 0.2/~g of endoproteinase 
Asp-N,  asparaginylendopeptidase, or endoproteinase  Lys-C (se- 
quencing  grade; Boehringer  Mannheim)  at 37~  for 18 h. The 
MCP fragments obtained were separated by reverse-phase HPLC, 
as described for the final purification of MCP. Amino acid sequences 
of proteins and peptides were determined in duplicate with an on- 
line sequencing in duplicate with an on-line sequencing system 
(477A/120A;  Applied Biosystems, Inc.).  Cysteine residues were 
confirmed after on falter reduction with tributylfosfine and modi- 
fication with 4-vinylpyridine. 
Assays.for Cheraotaxis and Activation of Cells.  PBMC were iso- 
lated  by hydroxyethyl  starch  sedimentation  and  FicoU-sodium 
metrizoate  centrifugation  (8). Neutrophils  were further purified 
by hypotonic  shock and Percoll gradient  centrifugation  (8). 
Chemotaxis under agarose was measured according to the method 
of Ndson et al. (12) and as previously described (8, 13). The titra- 
tion end-point,  corresponding  to I U/ml, was calculated from a 
dilution resulting in the half-maximal effective migration distance 
as compared with that obtained with human granulocyte chemo- 
tactic protein  (GCP)/IL-8  (13) or MCP-1 (8). 
Migration  of monocytes and granulocytes was also assessed by 
the microchamber (Neuro Probe Inc., Cabin John, MD) technique 
(8, 14). An optimal concentration  of purified human MCP-1 (8) 
or GCP/IL-8 (13) was used as a reference chemoattractant.  The 
chemotactic index was calculated from the number of cells migrated 
to the test sample divided by the number of cells migrated to the 
control medium. 
Release of gelatinase B was used as a parameter to measure mono- 
cyte or granulocyte  activation.  Purified  granulocytes  (5  x  106 
cells/ml) or adherent monocytes (2 h/37~  were stimulated (in 
serum-free medium) with test reagents for 45 min or 18 h, respec- 
tively. Supernatants were centrifuged to remove cells, and gelatinase 
activity was determined  by SDS/PAGE zymography  (15). 
In Vivo Infiltration of Leukoq/tes in Rabbit Skin.  New Zealand 
white rabbits were shaved at the abdomen and injected intrader- 
really with the indicated doses of homogeneous, pyrogen-free MCP 
preparations (100/xlAite,  eight sites/rabbit).  After  18 h, rabbits 
were killed and the injection sites were excised. Skin biopsies were 
processed for routine  histology, stained with hematoxylin-eosin, 
and microscopically examined. 
Results 
Isolation and Identification of Human MCP-2 and MCP-3. 
The monocTte chemotactic activity from stimulated MG-63 
cells was concentrated by adsorption to CPG beads and fur- 
ther purified by antibody affinity chromatography or heparin- 
Sepharose chromatography. Distinct monocyte chemotactic 
activities could subsequently be separated by cation-exchange 
FPLC (Fig.  1).  The predominant  activity eluted at 0.5 M 
NaC1 in the gradient and corresponded to two major protein 
bands (10 and 16 kD) previously identified as MCP-lo~ and 
MCP-1B (6, 8). In addition, a second and a third MCP peak 
were recovered at 0.7 and 0.6 M NaC1, and were designated 
MCP-2 and MCP-3,  respectively (Fig.  1). 
To investigate the nature of these additional MCP peaks 
from FPLC, their activities were purified to homogeneity (in 
parallel with MCP-1) by reverse-phase HPLC. Fig. 2 A shows 
that MCP-1 eluted on HPLC at m26% acetonitrile, whereas 
MCP-2 and MCP-3 eluted at 30% and 27.5% acetonitrile, 
respectively. This further indicated that the latter activities 
represent distinct factors. Homogeneous MCP-1 remained het- 
erogenous upon SDS-PAGE in that multiple molecular mass 
bands (10,  12, 14, and 16 kD) were eluting in single HPLC 
fractions (Fig.  2 B). Sequence analysis revealed that all these 
MCP-1  proteins  were  NH2-terminally  blocked.  Identity 
with authentic  MCP-1 was confirmed by sequencing frag- 
ments (from residues 3-26 and 54-60 of the mature protein) 
of an Asp-N endoproteinase digest (Fig.  3). 
MCP-2 and MCP-3 were found to reside in a 7.5- and 11-kD 
protein, respectively (Fig. 2 B). MCP-2 and MCP-3 also had 
a blocked NH2-terminus,  but could be identified through 
fragmentation of (twice) 4/~g pure MCP-2 and MCP-3 with 
trypsin or Asp-N endoproteinase  and (once) 4/~g MCP-3 
with asparaginyl- or Lys-C endoproteinase.  Sequence anal- 
ysis of the obtained fragments, separated by HPLC, demon- 
strated that both MCP-2 and MCP-3 have a primary struc- 
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Figure 1.  Separation  ofMCP-1,  MCP-2, and MCP-3 by cation-~hange 
FPLC. Concentrated MG-63 cell supernatant was loaded on a Mono S 
column at pH 4.0 and duted (1-ml fractions) with a linear NaCl gradient 
(-- -). Absorbance  (  - ) was monitored at 280 nm. Fractions were tested 
for monocyte chemotactic activity (histograms) in the agarose assay. 
60  Novel  Monocyte  Chemotactic Proteins of the Intcrlcukin 8 Family Figure 2.  Purification of MCP-1, 
MCP-2,  and  MCP-3  to  homo- 
geneity by reverse-phase  HPLC. (.4) 
MCP-1, MCP-2, and MCP-3 from 
FPLC were loaded separately on a 
C-8 Aquapore RP-300 column and 
eluted  (0.4-ml  fractions) with an 
acetonitrile gradient (-- -). Absor- 
bance was monitored at  220 nm 
(  ). (B) SDS/PAGE of HPLC- 
purified  MCPs. Active  fractions 
were run with 5/~1 (MCP-lct and 
/3) or 20 gl (MCP-2 and MCP-3) 
on a linear gel under reducing con- 
ditions and silver stained. Relative 
molecular mass markers were as in- 
dicated in Materials and Methods. 
Numbered arrows indicate MCP ac- 
tivity (histograms) measured in the 
agarose assay  and the corresponding 
protein bands, respectively. 
ture  related  to,  but  distinct  from,  MCP-1  (Fig. 3).  The 
alignment of  multiple overlapping  sequence  fragments allowed 
for the identification  of nearly the complete primary struc- 
ture of MCP-2  and about 90% of that of MCP-3.  MCP-2 
and MCP-3 showed 62.5%  and 73% identity with MCP-1, 
respectively. A search in the EMBL/Swiss-Prot  Band (PC/ 
Gene release, February 1992) did not provide evidence for 
identity of the sequences with any known protein structure. 
However, a profound literature search  revealed  that the MCP-2 
sequence is identical to the cDNA-derived sequence of HC14, 
an IFN-7-inducible gene in monocytes (16). The cDNA se- 
quence of HC14 has not yet been disclosed and the corre- 
sponding protein has not been expressed to permit biolog- 
ical characterization. 
Biological Characterization of  MCP-2 and MCP-3 In Vitro and 
In Vivo.  In the assay measuring migration under agarose, 
MCP-2  and MCP-3  showed specific activities (1 U  corre- 
sponding to  a half-maximal  migration distance)  of ~10  4 
U/rag, comparable with that of MCP-1. In contrast, at the 
highest dose tested, no neutrophil chemotactic activity could 
be  detected  with  all  three  MCP  species (<103 U/mg), 
whereas  Ib8 had a specific activity  of 10  s U/mg for neu- 
trophils. 
Fig. 4 compares the chemotactic  potency (minimum effec- 
tive concentration) and efficacy (maximal effect at optimal 
concentration)  of  MCP-1,  MCP-2,  and  MCP-3  in  the 
microchamber migration assay. All three MCPs are most effica- 
cious for monocyte  chemotaxis at 1 nM, the effect of MCP-3 
being somewhat lower. The minimum effective concentra- 
tion was 0.1-0.3 nM. The spedfic activity (1 U corresponding 
to a stimulation index of 2.5) in this monocyte  microchamber 
assay was calculated to be 7  x  105, 4  x  10  s, and 4  x  105 
U/mg for MCP-1, MCP-2, and MCP-3, respectively. In con- 
trast,  their specific activity for neutrophils  was found to be 
<  5  x  104 U/rag, whereas IL-8 scored >2  x  106 U/mg. 
It was verified whether MCP-1, -2, and -3 could activate 
monocytes to secrete gelatinase B. Although by their adher- 
ence monocytes can spontaneously secrete gelatinase activity, 
i  5  I0  15  20  25  30  35  40  45  50  55  fi0  65  70  75  (% Iden- 
tity) 
human MCP-I  OPDAINAPVTCCYNFTNRK  X  SVQRLASYRR  ITS  SKC  PKEAVI  FKT  I  VAK  E  I  CADPKQKNVQDSMDHLDKQTQTPKT  (I00) 
human  MCP-2  DSVS  I  P  ITCCFNVI  NRK  I  p  IQRLESYTRITNIQCPKEAVI  FKT  GKEVCADPKERWVRDS~d~Q  I  FQI~hKP  (62) 
human  MCP-3  KSTTCCYRF  I  NKK  I  PKQRLE  STRRTTSSHCPREAVI  FK  DKE  I  CADPTQKWV~OFMEIqLDKKTQTPKL  (73) 
murine  JE  QPDAVNAPLTCCYSFTSKIqIPMSRLESYI~ITSSRCPKEA~CADPKKEWVQTYIK~LDRHQWRSEPT~"...  (  55  } 
rat MCP-I  QP~AVIIAPLTCCYSFT~KII~ITSSRCPE~LV%qrCTKIggREICADPIO~EMVQKYI~SETTV...  (51) 
rabbit MCP-I QpDAVMSPVTOd~TrL-RKTI~IRSTKCPTdgAVIPIqTKLAKGICADPEQ  r~K,~-LT...  (75} 
bovine MCP-1 QPDAINSQVACCTTFRSKKIS~RId~n~tRVTSSKCPKEAVIFKTILGKELCADPKQ~WVQDSI~  (72) 
Figure 3.  Amino acid sequence 
alignments  of MCPs from different 
species. The MCP-2 and MCP-3 se- 
quences were experimentally deter- 
mined from  overlapping  peptide 
fragments obtained after trypsin, en- 
doproteinase  Asp-N,  asparaginyl- 
and  Lys-C  endoproteinase  diges- 
tions. The other protein sequences 
are cDNA derived (17, 18, 21-24). 
Values in parentheses indicate the 
percentage of sequence similarity 
with human MCP-1. The sequence 
data of  MCP-2 and MCP-3 are avaib 
able from EMBL/Gen.Bank/DDBJ 
under accession numbers P80075 
and P80098, respectively. 
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Figure 4.  Comparison of the chemotactic effect of MCPs on mono- 
cytes and neutrophils.  Pure preparations of MCP-1 (O, O), MCP-2 (A, 
A), MCP-3 (ll, [3), and Ib8 (V) were compared for chemotactic  ac- 
tivity on monocytes (filled symbols) and neutrophils (open symbols) using 
the microchamber  assay. Values are averages of three independent ex- 
periments. 
the production of the 85-kD enzyme could be enhanced by 
treatment with either MCP-1, -2, or -3 (data not shown). 
In contrast, on neutrophils no gelatinase B release was ob- 
served with any of the MCP molecules, whereas these cells 
were found to  release this  enzyme after  treatment with 
I1,8 (15). 
Finally, the three factors were compared for their chemo- 
tactic potency after administration in vivo (Fig. 5). Purified, 
endotoxin-free material was therefore injected intradermally 
into rabbit skin (10-500 ng/site). A selective and prominent 
infiltration  of monocytes was noticed with MCP-1, -2, and 
-3. At 10 ng/site, MCP-2 and MCP-3 were still able to elicit 
an intradermal monocyte recruitment. The appropriate con- 
trol (pyrogen-free saline) did not influence leukocyte  infiltra- 
tion. The monocyte infiltration was characterized  by clustering 
of cells, visible monocyte adherence to endothelia (margina- 
tion), and accumulation of monocytes around the site of in- 
jection (Fig. 5). 
Discussion 
This study describes the identification of two novel  mono- 
cyte chemotactic factors isolated from human tumor cells. 
Since the corresponding 7.5- and 11-kD proteins show high 
structural and functional similarity with MCP-1 (8, 17, 18), 
they are designated MCP-2 and MCP-3, respectively. Based 
on the conservation of four cysteine residues, these'molecules 
can be classified in a family of small proinflammatory pro- 
teins  (1-8).  In  accordance  with  most  members  of  this 
chemokine family, MCP-2  and MCP-3  show affinity  for 
heparin. 
Almost the complete primary structure of MCP-2 (95 %) 
could be disclosed by sequencing  fragments of the NHz- 
terminally blocked mature protein. Out of 72 residues deter- 
mined, 45 (62.5%)  were found to be identical to those in 
MCP-1. Although the MCP-2  sequence was not contained 
in the EMBL/Swiss-Prot  Bank, the primary structure of this 
chemotactic factor fully corresponded to that of the cDNA- 
derived sequence of  leukocyte-derived  HC14. The HC14 gene 
encodes a protein of 99 amino acids, including a signal pep- 
tide of 23 residues (16). The primary structure of the mature 
MCP-3  protein,  a third chemotactic factor for monocytes, 
was almost completely determined. From the fragments (67 
residues) sequenced, it can be deduced that MCP-3 is more 
closely related to human MCP-1  (73%  similarity)  than to 
MCP-2  (60%  similarity). 
All three MCPs possess similar specific  activities in mono- 
cyte chemotaxis assays. Concordantly with MCP-1, MCP-2 
and -3 are selective attractants  because no significant effect 
could be observed on neutrophils.  The specific activity of 
MCPs for neutrophil chemotaxis is at least 50-fold lower than 
that of II.-8. The effect on other cell types (e.g., lympho- 
cytes) needs to be investigated in more detail. 
MCP-1 and II.-8 exert chemotactic activity in vivo in that 
they cause both locally and systematically a recruitment of 
monocytes and neutrophils,  respectively (13, 19). Similarly, 
MCP-2 and MCP-3 were found to induce monocyte infiltra- 
tion after intradermal injection in rabbit skin. Occasionally, 
few neutrophils (<5% of total leukocyte counts) were also 
noticed in the skin section. It was also consistently observed 
that the monocytes occurred in "clusters" or "nests" at the 
injection site, and marginating cells were sometimes seen in 
contact with the endothelial lining of the venules. This effect 
seemed most pronounced with MCP-3. 
Murine macrophage inflammatory protein 1 (20) and other 
human molecules of this subfamily, such as RANTES (7), 
have been reported to possess monocyte chemotactic activity. 
However,  the structural  similarity  of these proteins  with 
MCP-1 is weaker than that of MCP-2 and -3. Since MCPs 
isolated from other species, such as the mouse (21) and the 
rat (22), show comparable sequence homology with the three 
human MCPs,  it cannot be concluded whether these pro- 
teins actually represent  the homologue of human MCP-1. 
In contrast,  rabbit (23) and bovine (24) MCPs are structur- 
ally more related  to  human MCP-1  and  MCP-3  than  to 
MCP-2. 
Unless the tumor cells were stimulated, none of these low 
molecular  mass proteins, including MCP-I, -2, and -3, could 
be recovered by purification from cell supernatants.  If cells 
were treated for 48 h with semi-purified leukocyte-derived 
cell supernatants (containing IL-1, II,6, IFN-% and possibly 
other cytokines), secretion of MCP-3 and MCP-1 was rather 
consistent, whereas that of MCP-2 remained variable. IFN-3' 
has been reported to be a major inducer of HC14/MCP-2 
mRNA in monocytes (16). Induction of  MCP-3 was observed 
in MG-63 cells stimulated with pure II-13 under serum-free 
62  Novel Monocyte Chemotactic  Proteins of the Interleukin 8 Family Figure 5.  Infiltration  of monocytes 
in rabbit skin after intradermal  injec- 
tion with human  MCPs.  Different  doses 
of MCP-1, -2,  and -3,  (50 and 500 
ngAite) in 100 gl pyrogenfree  physio- 
logical  saline  (0.9% NaC1, used  as con- 
trol) were  injected.  Shown  are represen- 
tative histological  sections  of the skin 
biopsies at 18 h after  injection  (x 300). 
MCP-3  (500 ng/site) at  x300  is 
magnified  from the frame  at x 75 (/eft, 
bottom). This x 75 magnification  clearly 
shows the injection  site and the frame 
was drawn at the border of the in- 
tradermal papula. 
conditions (not shown). Addition of 2% FCS further increased 
the production level, indicating that the regulation of MCP 
secretion is complex. The possibility that MCP-3 could rep- 
resent the bovine equivalent of MCP-1 (copurified from the 
serum additive) was excluded since both MCPs were pro- 
duced under serum-free conditions or in the presence of human 
serum. As a control, MCP was isolated from bovine kidney 
cells and was found to possess a protein sequence distinct from 
that of the human MCPs (data not shown). Furthermore, 
isolation of a bovine MCP from seminal plasma (24) revealed 
a primary structure still different from that of bovine kidney 
cell-derived MCP. The molecular cloning of the MCP-2 and 
MCP-3 genes will enable a detailed study of the expression 
in various cell  systems. 
Tumor cells  seem  to be good producers of chemotactic 
factors.  It could therefore be questioned whether the MCPs 
identified here play a role in the control of tumor cell growth 
and invasion.  Indeed, tumor-derived monocyte chemotactic 
activity is reportedly correlated with the presence of tumor- 
associated macrophages (9). MCP-activated monocytes might 
63  Van Damme  et  al. thus be important in tumor immune surveillance by inhibiting 
cell growth (19). Alternatively, we speculate that chemotactic 
substances might  promote invasion and metastasis by pro- 
tease secretion from the attracted and activated leukocytes. 
In conclusion, the structural and functional identification 
of two novel MCPs extends the growing list of molecules 
belonging to this superfamily ofproinflammatory cytokines. 
Since both new chemokines are equally active in vitro and 
in vivo when compared with MCP-1, the question remains 
why nature provides several of these closely related chemotactic 
factors.  It therefore remains essential to investigate whether 
some of these have still other unrelated biological functions 
or whether some could serve as antagonist of MCP or II.-8, 
for instance,  through  competition  for receptor binding. 
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